يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"HOMA"', وقت الاستعلام: 0.75s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Исследования выполнены в рамках госконтракта № 02.740.11.05.01. ФЦП «Научные и научно-педагогические кадры инновационной России на 2009-2013 гг» и тематического плана НИИ биологии ЮФУ на 2010-2011 годы.

    المصدر: Medical Herald of the South of Russia; № 3 (2012); 52-55 ; Медицинский вестник Юга России; № 3 (2012); 52-55 ; 2618-7876 ; 2219-8075 ; undefined

    وصف الملف: application/pdf

    العلاقة: https://www.medicalherald.ru/jour/article/view/1218/692Test; Cervical ripening and insufficiency: from biochemical and molecular studies to in vivo clinical examination / D. Schlembach [et al.] // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2009. – Vol. 144, № 1. – P. 70 – 76.; Суханова, Л.П. Родовспоможение в России – состояние, тенденции развития, пути совершенствования / Л.П. Суханова, С.А. Леонов // Социальные аспекты здоровья населения. – 2010. – № 2. – С. 15 – 17.; Adipokines: New Emerging Roles in Fertility and Reproduction / C. Tersigni [et al.] // Obstetrical & Gynecological Survey. – 2011. – Vol. 66. – № 1 – P. 47-63.; Unger, R. H. Diseases of liporegulation: new perspective on obesity and related disorders / R. H. Unger, L. Orci // FASEB J. – 2001. – 15. – P. 312–321.; Patrick, M. Obesity, insulin resistance, and pregnancy outcome / M. Patrick, В. Catalano // Reproduction. – 2010. – № 140. – P. 365- 371.; Craig, L. B. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss / L. B. Craig, R. W. Ke, W. H. Kutteh // Fertil. Steril. – 2002. – № 78. – P. 487–490.; Evaluation of the relationship between insulin resistance and recurrent pregnancy loss / N. Celik [et al.] // Ginekol. Pol. – 2011. – Vol. 82, № 4 – P. 272-275.; Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5 / J. H. Choi [et al.] // Nature. – 2010. – Vol. 22, № 6. – P. 451-456.; Angiotensin-(1-7) prevents diabetes-induced attenuation in PPARgamma and catalase activities / G. S. Dhaunsi [et al.] // Eur. J. Pharmacol. – 2010. – Vol. 63, №3. – P. 108 – 114.; Rosen, E.D. PPARγ : a nuclear regulator of metabolism, differentiation, and cell growth / E. D. Rosen, B. M. Spiegelman // J. Biol. Chem. – 2001. – № 276. – P. 37731 – 37734.; The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo / I. Bogacka [et al.] // Diabetes Care. – 2004. – Vol. 27, №7. – P. 1660-1667.; PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance / M. Guerre-Millo [et al.] // Diabetes. – 2001. – Vol. 50, № 12. – P. 2809-2814.; Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results / M. Stepien [et al.] // Med. Sci. Monit. – 2011. – Vol. 17, № 11. – P. 13-18.; Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases / Hui W. [et al.] // Ann. Rheum. Dis. – 2011. – Vol. 27, № 12. – P. 13-18.; Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone / R. Unal [et al.] // J. Clin. Endocrinol. Metab. – 2010. – Vol. 95, №6. – P. 2993 – 3001.; Insulin regulates leptin secretion from 3T3–L1 adipocytes by a PI 3 kinase independent mechanism / A. Zeigerera [et al.] // Experimental Cell Research – 2008. – Vol. 314. – № 11 – P. 2249-2256.; Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells / Z. Luo [et al.] // Endocrine. – 2009. – Vol. 36, № 1. – P. 60-69.с.; https://www.medicalherald.ru/jour/article/view/1218Test; undefined

  2. 2
    دورية أكاديمية

    المصدر: Medical Herald of the South of Russia; Том 9, № 1 (2018); 23-31 ; Медицинский вестник Юга России; Том 9, № 1 (2018); 23-31 ; 2618-7876 ; 2219-8075 ; 10.21886/2219-8075-2018-9-1

    وصف الملف: application/pdf

    العلاقة: https://www.medicalherald.ru/jour/article/view/642/441Test; Решетняк Т.М., Середавкина Н.В., Дыдыкина И.С., Насонов Е.Л. // Глюкокортикоиды в терапии системной красной волчанки. Клиницист. - 2013. - № 3-4. - С. 14-26.; Lupi I, Cosottini M, Caturegli P, Manetti L, Urbani C, Cappellani D et al. Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis. Eur J Endocrinol. 2017; 177(2):127-135. doi:10.1530/EJE-17-0123.; Suh S, Park MK. Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem. Endocrinol Metab (Seoul). 2017; 32(2):180-189. doi:10.3803/EnM.2017.32.2.180.; Румянцева С.А., Силина Е.В., Орлова А.С., Орлов В.А., Болевич С.Б. Гипергликемия и свободнорадикальный дисбаланс как прогностические маркеры острого нарушения мозгового кровообращения. // Анналы клинической и экспериментальной неврологии. - 2012. - Т. 6. № 4. - С. 26-29.; Martínez BB, Pereira AC, Muzetti JH, Telles FP, Mundim FG, Teixeira MA. Experimental model of glucocorticoid-induced insulin resistance. Acta Cir Bras. 2016; 31(10):645-649. doi:10.1590/S0102-865020160100000001.; Кондратьева Л.В., Панафидина Т.А., Герасимова Е.В., Горбунова Ю.Н., Попкова Т.В., Насонов Е.Л. Сахарный диабет и гипергликемия у больных ревматоидным артритом. // Современная ревматология. - 2014. - № 3. - С. 23-27. doi.org/10.14412/1996-7012-2014-3-23-27.; JensenDH, Aaboe K, Henriksen JE, Vølund A, Holst JJ, Madsbad S et al. Steroid-induced insulin resistance and impaired glucose tolerance are both associated with progressive decline of incretin effect in firstdegree relatives of patients with type 2 diabetes. Diabetologia. 2012;55(5):1406-16. doi:10.1007/s00125-012-2459-7.; Ha CH, Swearingin B, Jeon YK. Relationship of visfatin level to pancreatic endocrine hormone level, HOMA-IR index, and HOMA β-cell index in overweight women who performed hydraulic resistance exercise. J Phys Ther Sci. 2015; 27(9):2965-9. doi:10.1589/jpts.27.2965.; Tuzun S, Oner C, Dabak MR, Kasikci HO, Sargin M. Relation of Muscle Indices with Metabolic Parameters and C-Peptide in Type 2 Diabetes Mellitus. J Coll Physicians Surg Pak. 2017; 27(11):673-677. doi: 2740.; Leighton E, Sainsbury CA, Jones GC. A Practical Review of C-Peptide Testing in Diabetes. Diabetes Ther. 2017; 8 (3):475-487. doi:10.1007/s13300-017-0265-4.; Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients. J Am Acad Dermatol. 2017;76(2):201-207. doi:10.1016/j.jaad.2016.02.1241.; Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016; 15 (4):457-65. doi:10.1517/14740338.2016.1140743.; Movahedi M, Beauchamp ME, Abrahamowicz M, Ray DW, Michaud K, Pedro S et al. Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2016; 68 (5):1089-98. doi:10.1002/art.39537.; https://www.medicalherald.ru/jour/article/view/642Test